Eutropin

DRUG2 trials

Sponsors

LG Life Sciences, Daewoong Pharmaceutical Co. LTD.

Conditions

Growth Hormone DeficiencyPrader-Willi Syndrome

Phase 3

Study to Assess the Efficacy and Safety of Eutropin in Prader-Willi Syndrome

CompletedNCT02204163

LG Life SciencesPrader-Willi Syndrome

Start: 2014-06-30End: 2017-12-31Updated: 2019-06-27

Evaluation of Efficacy and Safety of Recombinant Somatroipn in Patients With Growth Hormone Deficiency

CompletedNCT02693522

Daewoong Pharmaceutical Co. LTD.Growth Hormone Deficiency

Start: 2003-10-31End: 2004-12-31Updated: 2016-02-29

Related Papers

Effects of recombinant human growth hormone treatment on growth, body composition, and safety in infants or toddlers with Prader-Willi syndrome: a randomized, active-controlled trial.

2019-09-1119 citations